Related Experiment Videos
Hypoglycemia in small-for-gestational-age neonates'
O Karahasanoğlu1, G Karatekin, R Köse
1Pediatric Clinics, Sişli Etfal Hospital, Istanbul.
The Turkish Journal of Pediatrics
|April 1, 1997
Summary
Hypoglycemia screening in small-for-gestational-age (SGA) neonates is crucial. This study found SGA infants have higher hypoglycemia rates, recommending continued screening for 48 hours postnatally.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
- Clinical Chemistry
Background:
- Neonatal hypoglycemia is a common concern, particularly in small-for-gestational-age (SGA) infants.
- Early detection and management are vital to prevent adverse neurodevelopmental outcomes.
Purpose of the Study:
- To determine the frequency of hypoglycemia in SGA neonates.
- To establish optimal screening intervals for hypoglycemia in this population.
Main Methods:
- Prospective study involving 25 SGA and 16 appropriate-for-gestational-age (AGA) neonates born after 37 weeks gestation.
- Blood glucose levels measured using test-strips at 2, 3, 6, 12, 24, and 48 hours of age.
- Serum glucose confirmation for values below 40 mg/dl.
Main Results:
- SGA neonates exhibited a significantly higher frequency of hypoglycemia compared to AGA neonates (p:0.097).
- Hypoglycemia was most frequently detected within the first three hours, at the sixth hour, and at 48 hours postnatally.
- Clinical signs were unreliable indicators of hypoglycemia.
Conclusions:
- Hypoglycemia screening in SGA neonates should extend up to 48 hours postnatally.
- Routine monitoring is essential, as clinical signs alone are insufficient for diagnosis.
- This supports evidence-based guidelines for neonatal hypoglycemia management.